<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">218</id>
  <title>T3D0217</title>
  <common-name>Potassium-40</common-name>
  <description>Potassium-40 is a naturally occurring radioactive isotope of potassium. Potassium is the chemical element with the symbol K and atomic number 19. Potassium is widely distributed in nature and is present in all plant and animal tissues. Potassium-40 comprises about 0.012% of naturally occurring potassium. It is the predominant radioactive component in human tissues and in most food. Potassium-40 has a half-life of 1.3 billion years and emits beta and gamma radiation. (L1134, L1851)</description>
  <cas>13966-00-2</cas>
  <pubchem-id>6328542</pubchem-id>
  <chemical-formula>K</chemical-formula>
  <weight>38.963710</weight>
  <appearance>Silvery-white metal.</appearance>
  <melting-point></melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral  (L1134) ; inhalation  (L1134)</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>The ionizing radiation produced by potassium causes cellular damage that includes DNA breakage, accurate or inaccurate repair, apoptosis, gene mutations, chromosomal change, and genetic instability. This leads to loss of normal cell and tissue homeostasis, and development of malignancy. Ionizing radiation that does not directly damage DNA can produce reactive oxygen intermediates that directly affect the stability of p53, an important enzyme in cell-cycle regulation, and produce oxidative damage to individual bases in DNA and point mutations by mispairing during DNA replication. (L1837)</mechanism-of-toxicity>
  <metabolism>Potassium-40 behaves in the body in the same manner as other potassium isotopes. Potassium is almost completely absorbed upon ingestion, moving quickly from the gastrointestinal tract to the bloodstream. The potassium-40 that enters the bloodstream after ingestion or inhalation is quickly distributed to all organs and tissues. Potassium-40 is eliminated from the body with a biological half-life of 30 days. The potassium content of the body is under strict homeostatic control (in which the amount retained is actively regulated by the body to achieve the normal range required for system functions), and it is not influenced by variations in environmental levels. Hence, the potassium-40 content in the body is constant, with an adult male having about 0.1 microcurie or 100,000 pCi. Each year this isotope delivers doses of about 18 millirem (mrem) to soft tissues of the body and 14 mrem to bone. Potassium cations are important in neuron function, influencing osmotic balance between cells and the interstitial fluid, allowing muscle contraction and the sending of all nerve impulses through action potentials, and maintaining fluid and electrolyte balance in the body. (L1134, L1851)</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>Internalized radionuclides that emit β particles are carcinogenic to humans (Group 1) (L2150). Potassium-40 undergoes beta decay.</carcinogenicity>
  <use-source>There are no specific commercial or medical uses associated with the radioactive properties of potassium-40. (L1134)</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Potassium-40 presents external as well as internal health hazard. The strong gamma radiation makes external exposure to this isotope a concern. While in the body, potassium-40 poses a health hazard from both the beta particles and gamma rays. The health hazard of  potassium-40 is associated with cell damage caused by the ionizing radiation that results from radioactive decay, with the general potential for subsequent cancer induction. (L1134)</health-effects>
  <symptoms>Exposure to high doses of ionizing radiation results in acute radiation syndrome, which can cause skin burns, hair loss, nausea, vomiting, dizziness, disorientation, low blood pressure, headache, fatigue, weakness, fever, birth defects, illness, infection, and death. (L1837, L1852)</symptoms>
  <treatment>Treatment reversing the effects of irradiation is currently not possible. Anaesthetics and antiemetics are administered to counter the symptoms of exposure, as well as antibiotics for countering secondary infections due to the resulting immune system deficiency. (L1852)</treatment>
  <created-at type="dateTime">2009-03-06T18:58:18Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:21:21Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id></kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id></chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Potassium-40</stitch-id>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>[40K]</moldb-smiles>
  <moldb-formula>K</moldb-formula>
  <moldb-inchi>InChI=1S/K/i1+1</moldb-inchi>
  <moldb-inchikey>InChIKey=ZLMJMSJWJFRBEC-OUBTZVSYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">39.964</moldb-average-mass>
  <moldb-mono-mass type="decimal">39.963998672</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>4886606</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
